Can you provide the average price target for MPLX LP stock?
20 analysts have analysed MPLX and the average price target is 58.54 USD. This implies a price decrease of -1.95% is expected in the next year compared to the current price of 59.7.
NYSE:MPLX • US55336V1008
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MPLX LP (MPLX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | UBS | Maintains | Buy -> Buy |
| 2026-03-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-03-05 | Stifel | Maintains | Buy -> Buy |
| 2026-02-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-05 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-12-01 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-11-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-14 | Stifel | Maintains | Buy -> Buy |
| 2025-07-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-03-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-03-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-03-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-06 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-01-13 | Barclays | Maintains | Overweight -> Overweight |
| 2024-12-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-19 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-15 | UBS | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.281B -2.86% | 11.933B 5.78% | 12.998B 8.92% | 13.331B 2.56% | 14.025B 5.21% | 15.06B 7.38% | 15.455B 2.62% | 15.756B 1.95% | 16.065B 1.96% | 16.381B 1.97% | |
| EBITDA YoY % growth | 6.129B -0.20% | 6.571B 7.21% | 7.294B 11.00% | 7.563B 3.69% | 8.144B 7.68% | 8.648B 6.19% | 8.827B 2.07% | 9.128B 3.41% | 9.421B 3.21% | 9.32B -1.07% | |
| EBIT YoY % growth | 4.916B 0.10% | 5.288B 7.57% | 5.943B 12.39% | 5.95B 0.12% | 6.37B 7.06% | 6.766B 6.22% | 7.05B 4.20% | 7.243B 2.74% | N/A | N/A | |
| Operating Margin | 43.58% | 44.31% | 45.72% | 44.63% | 45.42% | 44.93% | 45.62% | 45.97% | N/A | N/A | |
| EPS YoY % growth | 3.81 1.60% | 4.21 10.50% | 4.82 14.49% | 4.65 -3.61% | 5.08 9.37% | 5.48 7.87% | 5.79 5.70% | 5.99 3.35% | 6.27 4.77% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.10 0.04% | 1.13 9.48% | 1.19 -21.54% | 1.23 5.31% | 1.23 11.69% | 1.28 13.52% | 1.34 12.05% | 1.31 6.37% |
| Revenue Q2Q % growth | 3.212B 2.82% | 3.257B 8.46% | 3.485B -3.70% | 3.536B 8.73% | 3.533B 9.99% | 3.585B 10.07% | 3.66B 5.02% | 3.739B 5.74% |
| EBITDA Q2Q % growth | 1.816B 7.33% | 1.845B -5.04% | 1.921B -31.32% | 1.986B -29.92% | 1.993B 9.75% | 2.026B 9.81% | 2.073B 7.91% | 2.096B 5.54% |
| EBIT Q2Q % growth | 1.428B 4.54% | 1.438B 11.21% | 1.497B -16.88% | 1.551B 4.59% | 1.55B 8.54% | 1.605B 11.61% | 1.66B 10.89% | 1.702B 9.74% |
All data in USD
20 analysts have analysed MPLX and the average price target is 58.54 USD. This implies a price decrease of -1.95% is expected in the next year compared to the current price of 59.7.
MPLX LP (MPLX) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of MPLX LP (MPLX) is 1.1 USD and the consensus revenue estimate is 3.21B USD.
The number of analysts covering MPLX LP (MPLX) is 20.